Baljevic, Muhamed http://orcid.org/0000-0002-0630-8458
Zaman, Shadia
Baladandayuthapani, Veerabhadran
Lin, Yan Heather
de Partovi, Claudia Morales
Berkova, Zuzana
Amini, Behrang
Thomas, Sheeba K.
Shah, Jatin J.
Weber, Donna M.
Fu, Min
Cleeland, Charles S.
Wang, Xin Shelley
Stellrecht, Christine M.
Davis, Richard E.
Gandhi, Varsha
Orlowski, Robert Z.
Funding for this research was provided by:
National Cancer Institute (NCI) to MD Anderson Cancer Center in the form of the SPORE in Multiple Myeloma (P50 CA142509)
Cancer Center Support Grant (P30 CA16672)
Cancer Therapy Evaluation Program (CTEP) grant (N01 CM-2011-0039)
Leukemia and Leukemia Society Translational Research Program Award
Multiple Myeloma SPORE
National Cancer Institute (U10 CA032102, R01 CA184464, CA194264)
MD Anderson Cancer Center High-Risk Multiple Myeloma Moon Shot
Brock Family Myeloma Research Fund
Yates Ortiz Myeloma Fund
Diane and John Grace Family Foundation
Article History
Received: 27 July 2016
Accepted: 14 March 2017
First Online: 23 March 2017
Compliance with ethical standards
:
: The authors declare no conflicts of interest relevant to this study.